Searchable abstracts of presentations at key conferences in endocrinology
Endocrine Abstracts (2003) 6 OC24

SFE2003 Oral Communications Neuroendocrinology (8 abstracts)

PACAP STIMULATES PHOSPHORYLATION AND LIGAND-BINDING ACTIVITY OF STEROIDOGENIC FACTOR-1 (SF-1) IN alphaT3-1 GONADOTROPHS

RC Fowkes 1,2 , M Desclozeaux 2 , HA Ingraham 2 & JM Burrin 1


1Endocrinology, Barts & the London School of Medicine & Dentistry, London, UK; 2Physiology, University of California, San Francisco, USA.


The orphan nuclear receptor, steroidogenic factor-1 (SF-1) regulates gonadotroph development and gene expression. In the absence of an identified ligand, SF-1 has been shown to be constitutively active and recent studies reveal that post-translational modification may regulate its transcriptional activity. The Ser 203 residue, proximally located to helix 1 of the ligand binding domain (LBD) of SF-1, resides in a consensus MAPK phosphorylation site, and is required for full transcriptional activity. We have investigated the post-translational modification of SF-1 in alphaT3-1 gonadotrophs, and examined the influence upon hormone-stimulated gene transcription in vitro. alphaT3-1 cells were co-transfected with increasing concentrations of wild-type or S203A mutant SF-1 and a human glycoprotein hormone alpha-subunit promoter-luciferase construct (-517alphaLUC), before stimulation with 0 or 100 nM PACAP for 8 h. Basal -517alphaLUC activity was enhanced following wild-type SF-1 over-expression (by 7.4+1.5-fold, P<0.01), but not in the presence of the S203A mutant. Furthermore, the S203A mutant reduced the PACAP-stimulated activation of -517alphaLUC to 51.1+11% (P<0.05). Using a modified mammalian 2-hybrid assay, alphaT3-1 cells were co-transfected with Gal4-hinge-helix-1-SF-1 or Gal4-S203A-hinge-helix-1-SF-1 and the activation domain of VP16-helix-2-12-SF-1, and the Gal4RE-LUC reporter. PACAP stimulation (100 nM, 8h) enhanced basal LBD activity by up to 10-fold (P<0.01), but the S203A mutation abolished this effect. Co-transfection of MAP kinase phosphatase-1 or treatment with MAPK kinase (MEK) inhibitor (UO126, 1 mM) also inhibited the PACAP effect (to 64.2+4.3% and 53.5+9% of control, respectively P<0.01). Finally, Western blotting of PACAP-stimulated alphaT3-1 cells revealed enhanced phosphorylation of endogenous SF-1 at Ser 203 within 5 min, an effect which was inhibited by blockade of MEK (UO126). Collectively, these data are the first to describe post-translational modification of SF-1 in gonadotrophs and suggest that MAPK-dependent re-modelling of the SF-1 LBD contributes to PACAP-stimulated gene transcription.

Volume 6

194th Meeting of the Society for Endocrinology and Society for Endocrinology joint with Diabetes UK Endocrinology and Diabetes Day

Society for Endocrinology 

Browse other volumes

Article tools

My recent searches

No recent searches.